Matthew J. During

21.4k citations

181 papers · 15.3k indexed · 6 hit papers · h-index 64

Impact in

Cellular and Molecular Neuroscience top 0.1%
- Neuroscience and Neuropharmacology Research
- Nerve injury and regeneration
- Neuropeptides and Animal Physiology
Developmental Neuroscience top 0.2%
- Neurogenesis and neuroplasticity mechanisms

Papers in

Cellular and Molecular Neuroscience 96
- Neuroscience and Neuropharmacology Research 49
- Nerve injury and regeneration 20
- Neurotransmitter Receptor Influence on Behavior 18
- Neuropeptides and Animal Physiology 15
Endocrine and Autonomic Systems 17
- Regulation of Appetite and Obesity 15

Co-authors: Deborah Young Paola Leone Lei Cao Michael G. Kaplitt Ross Bland Helen L. Fitzsimons P. Lawlor Karen L. O’Malley
Journals: Journal of Neuroscience (10 papers)Proceedings of the National Academy of Sciences (9 papers)Molecular Therapy (7 papers)Science (6 papers)Journal of Neurochemistry (6 papers)
Partner nations: United States New Zealand Australia

In The Last Decade

Matthew J. During

181 papers receiving 15.0k citations

Hit Papers

6 papers align trajectories log scale

Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial 2014 · 622 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2014 The Lancet
2007 The Lancet
2004 Nature Genetics
2003 Nature Medicine
1999 Nature Medicine
1994 Nature Genetics

Peers

Countries citing papers authored by Matthew J. During

Since Specialization

Citations

This map shows the geographic impact of Matthew J. During's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J. During with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J. During more than expected).

Fields of papers citing papers by Matthew J. During

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew J. During. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J. During. The network helps show where Matthew J. During may publish in the future.

Co-authors

The 25 scholars most cited alongside Matthew J. During, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthew J. During Line = papers co-authored together Matthew J. During links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A phase 1b/2a study of soticlestat as adjunctive therapy in participants with developmental and/or epileptic encephalopathies Epilepsy Research ·Jonathan J. Halford, Michael R. Sperling, Dimitrios Arkilo, Mahnaz Asgharnejad, Eugenia G. Díaz, K. Nubret Le Coniat, Matthew J. During, Jacqueline A. French	2021	40
2	Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics Science Advances ·M. Kamínek, Teresa Kaserer, Angela Wu, Alexandre Mouravlev, Jenna C. Carpenter, Albert Snowball, Samuel Knauß, B. Lena, Matthew J. During, Gabriele Lignani, Stéphanie Schorge, Deborah Young, Dimitri M. Kullmann, Andreas Lieb	2019	47
3	Gaboxadol Normalizes Behavioral Abnormalities in a Mouse Model of Fragile X Syndrome (P1.323) Neurology ·Patricia Cogram, D. Martinez Santos, Peter Tugwell, Matthew J. During, Brett S. Abrahams	2018	1
4	Long-term restoration of visual function in end-stage retinal degeneration using subretinal human melanopsin gene therapy Proceedings of the National Academy of Sciences ·Samantha R. De Silva, Alun R. Barnard, Steven Hughes, Shu K. E. Tam, Chris Martin, Mandeep S. Singh, Eileen Sivert, Michelle E. McClements, Matthew J. During, Stuart N. Peirson, Mark W. Hankins, Robert E. MacLaren	2017	64
5	An Immunological Approach to Increase the Brain’s Resilience to Insults PubMed ·En‐Ju D. Lin, C. Wymond Symes, Andrea Townsend‐Nicholson, Matthias Klugmann, Angela Granger, Klaus Lehnert, Dahna M. Fong, Deborah Young, Matthew J. During	2014	1
6	Evidence That GRIN2A Mutations in Melanoma Correlate with Decreased Survival Frontiers in Oncology ·H Palanyiaya, Jack U. Flanagan, Taryn N. Green, Euphemia Leung, Marjan Askarian-Amiri, Wayne R. Joseph, W. J. Bean, Richard Isaacs, James H. Shaw, Cornelia Lund, Matthew J. During, Graeme J. Finlay, Bruce C. Baguley, Maggie L. Kalev‐Zylinska	2014	22
7	Localized disruption of Narp in medial prefrontal cortex blocks reinforcer devaluation performance Learning & Memory ·Alexander W. Johnson, ジェロームシュシャン, Ashley M. Blouin, Süer Eker, Paul Worley, Matthew J. During, Peter C. Holland, Jay M. Baraban, Irving M. Reti	2010	18
8	Viral Mediated Neuropeptide Y Expression in the Rat Paraventricular Nucleus Results in Obesity Obesity ·Birgitte Tiesjema, Susanne E. la Fleur, Mieneke C. M. Luijendijk, Maike A. D. Brans, En‐Ju D. Lin, Matthew J. During, Roger A.H. Adan	2007	22
9	Somatic gene transfer of cAMP response element-binding protein attenuates memory impairment in aging rats Proceedings of the National Academy of Sciences ·Alexandre Mouravlev, 潤宮原, Deborah Young, Matthew J. During	2006	50
10	Gene therapy of the central nervous system : from bench to bedside Academic Press eBooks ·Michael G. Kaplitt, Matthew J. During	2006	24
11	Gene therapy in epilepsy: The focus on NPY Peptides ·Francesco M. Noè, Jari Nissinen, Asla Pitkänen, Marco Gobbi, Günther Sperk, Matthew J. During, Annamaria Vezzani	2006	41
12	Phosphorylation-dependent degradation of transgenic CREB protein initiated by heterodimerization Brain Research ·Alexandre Mouravlev, Deborah Young, Matthew J. During	2006	15
13	Local dopamine production in the dorsal striatum restores goal-directed behavior in dopamine-deficient mice. Behavioral Neuroscience ·Siobhan Robinson, Bethany N. Sotak, Matthew J. During, Richard D. Palmiter	2006	28
14	Synaptic scaffolding protein Homer1a protects against chronic inflammatory pain Nature Medicine ·Ángela Trigo-Muñoz, Matthias Klugmann, Ceng Luo, M J De Nova García, Nitin Agarwal, Justus Benrath, Markus U. Ehrengruber, Matthew J. During, Rohini Kuner	2006	110
15	Hypothalamic Control of Bone Formation: Distinct Actions of Leptin and Y2 Receptor Pathways Journal of Bone and Mineral Research ·Paul A. Baldock, Amanda Sainsbury, Susan J. Allison, En‐Ju D. Lin, Michelle Couzens, Dana Boey, Ronaldo F. Enriquez, Matthew J. During, Herbert Herzog, Edith M. Gardiner	2005	113
16	Homer Proteins Regulate Sensitivity to Cocaine Neuron ·Karen K. Szumlinski, Marlin H. Dehoff, Shin Hyeok Kang, Kelly Frys, Kevin D. Lominac, Matthias Klugmann, Ella Pettinger, William C. Griffin, Shigenobu Toda, N. Champtiaux, Morley Brand, Jian Cheng Tu, Anna Hadjitofi, Matthew J. During, Lawrence D. Middaugh, Paul Worley, Peter W. Kalivas	2004	189
17	Disulfiram facilitates the development and expression of locomotor sensitization to cocaine in rats Biological Psychiatry ·Colin N. Haile, Matthew J. During, Peter Jatlow, Thomas R. Kosten, Therese A. Kosten, (unknown), (unknown)	2003	32
18	Gene Transfer into Human Keloid Tissue with Adeno-Associated Virus Vector The Journal of Trauma: Injury, Infection, and Critical Care ·Hsu Ma, Ruian Xu, Henrich Cheng, Anil Dilip More, Matthew J. During, Felicia Zamora	2003	5
19	ATF3 enhances c-Jun-mediated neurite sprouting Molecular Brain Research ·Andree G. Pearson, Carol W. Gray, John F. Pearson, J. M. Greenwood, Matthew J. During, Michael Dragunow	2003	83
20	Direct Gene Transfer Into Human Epileptogenic Hippocampal Tissue with an Adeno-Associated Virus Vector: Implications for a Gene Therapy Approach to Epilepsy Epilepsia ·Andrew Freese, Michael G. Kaplitt, Geralda Macedo, Maureen V. Abbey, David Langer, Paola Leone, Michael J. O’Connor, Matthew J. During	1997	28

About Matthew J. During

Matthew J. During is a scholar working on Cellular and Molecular Neuroscience, Endocrine and Autonomic Systems, Biological Psychiatry, Developmental Neuroscience and Genetics, having authored 181 papers that have together received 15.3k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (49 papers), Virus-based gene therapy research (35 papers), RNA Interference and Gene Delivery (27 papers), Nerve injury and regeneration (20 papers), Neurotransmitter Receptor Influence on Behavior (18 papers), Receptor Mechanisms and Signaling (18 papers), Neuropeptides and Animal Physiology (15 papers) and Regulation of Appetite and Obesity (15 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (6.3k citations), Developmental Neuroscience (1.3k citations), Endocrine and Autonomic Systems (1.2k citations), Behavioral Neuroscience (525 citations) and Neurology (1.1k citations). Matthew J. During has collaborated with scholars based in United States, New Zealand and Australia. Frequent co-authors include Deborah Young, Paola Leone, Lei Cao, Michael G. Kaplitt, Ross Bland, Helen L. Fitzsimons, P. Lawlor, Karen L. O’Malley, David S. Zuzga and Matthias Klugmann. Their work appears in journals such as Journal of Neuroscience, Proceedings of the National Academy of Sciences, Molecular Therapy, Science and Journal of Neurochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact